Non-Comparative Study of Fluconazole in Patients With Serious Mycoses and Who Cannot Be Treated With Conventional Antifungal Therapy
The primary purpose of this protocol is to provide fluconazole for the treatment of individual patients who require therapy for serious or life-threatening systemic fungal infection, who have failed on conventional antifungal therapy or have had unacceptable reactions to conventional antifungal therapy, and who are ineligible for other established fluconazole clinical trial protocols.
|Study Design:||Primary Purpose: Treatment|
|Official Title:||Non-Comparative Study of Fluconazole in Patients With Serious Mycoses and Who Cannot Be Treated With Conventional Antifungal Therapy|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00002038
|United States, Connecticut|
|Pfizer Central Research|
|Groton, Connecticut, United States, 06340|